Publications by authors named "Helmut Ellemunter"

Claim this Profile
M
Monitoring ETI effects over 1.7 years in an infant treated in utero, via breast milk and granules by repeated faecal elastase measurements.
Dorothea Appelt, Teresa Fuchs, Johannes Eder, Katharina Niedermayr, Anja Siedl, Helmut Ellemunter

J Cyst Fibros· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytokines Measured in Nasal Lavage Compared to Induced Sputum in Patients with Mild Cystic Fibrosis.
Teresa Fuchs, Artemis Vasiliadis, Manuela Zlamy, Anja Siedl, Katharina Niedermayr, Helmut Ellemunter

Int J Mol Sci· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[CF Lung Disease - a German S3 Guideline: Pseudomonas aeruginosa].
Carsten Schwarz, Jutta Bend, Helge Hebestreit, Michael Hogardt, Christian Hügel, Helmut Ellemunter

Pneumologie· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[CF Lung Disease - a German S3 Guideline: Pseudomonas aeruginosa].
Carsten Schwarz, Jutta Bend, Helge Hebestreit, Michael Hogardt, Christian Hügel, Helmut Ellemunter

Pneumologie· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of cytokines in nasal lavage samples of patients with cystic fibrosis: comparison of two different cytokine detection assays.
Teresa Fuchs, Manuela Zlamy, Thomas Zöggeler, Dorothea Appelt, Katharina Niedermayr, Helmut Ellemunter

BMC Pulm Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Bridging of host-microbiota tryptophan partitioning by the serotonin pathway in fungal pneumonia.
Giorgia Renga, Fiorella D'Onofrio, Marilena Pariano, Roberta Galarini, Carolina Barola, Helmut Ellemunter

Nat Commun· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Assessment of Antibody Response to COVID-19 Vaccination in People with Cystic Fibrosis and Solid Organ Transplantation.
Teresa Fuchs, Dorothea Appelt, Helmut Ellemunter

Vaccines (Basel)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of elexacaftor/tezacaftor/ivacaftor on lung function, nutritional status, pulmonary exacerbation frequency and sweat chloride in people with cystic fibrosis: real-world evidence from the German CF Registry.
Sivagurunathan Sutharsan, Stefanie Dillenhoefer, Matthias Welsner, Florian Stehling, Folke Brinkmann, Helmut Ellemunter

Lancet Reg Health Eur· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bridging of host-microbiota tryptophan partitioning by the serotonin pathway in fungal pneumonia.
Giorgia Renga, Fiorella D'Onofrio, Marilena Pariano, Roberta Galarini, Carolina Barola, Helmut Ellemunter

Nat Commun· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aryl Hydrocarbon Receptor Agonism Antagonizes the Hypoxia-driven Inflammation in Cystic Fibrosis.
Marilena Pariano, Matteo Puccetti, Claudia Stincardini, Valerio Napolioni, Leonardo Gatticchi, Helmut Ellemunter

Am J Respir Cell Mol Biol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early and sustained improvements of lung clearance index from two to sixteen weeks of elexacaftor/tezacaftor/ivacaftor therapy in patients with cystic fibrosis-a real world study.
Dorothea Appelt, Gratiana Steinkamp, Sarah Sieber, Helmut Ellemunter

Front Pharmacol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is There a Difference in Immune Response to SARS-CoV-2 Vaccination between Liver and Lung Transplant Patients with Cystic Fibrosis?
Teresa Fuchs, Dorothea Appelt, Helmut Ellemunter

Vaccines (Basel)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized medicine with drugs targeting the underlying protein defect in cystic fibrosis: is monitoring of treatment response necessary?
Katharina Niedermayr, Verena Gasser, Claudia Rueckes-Nilges, Dorothea Appelt, Johannes Eder, Helmut Ellemunter

Ther Adv Chronic Dis· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer in Cystic Fibrosis: Do Not Neglect Gynecologic Cancers.
Dorothea Appelt, Gratiana Steinkamp, Helmut Ellemunter

Chest· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arm muscle area for the longitudinal assessment of nutritional status in paediatric patients with cystic fibrosis - A single centre experience.
Helmut Ellemunter, Markus Dumke, Gratiana Steinkamp

J Cyst Fibros· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
REAL-world clinical effectiveness of ivacaftor therapy in the first 24 months in two infants with cystic fibrosis and different gating mutations-A case report.
Teresa Fuchs, Dorothea Appelt, Katharina Niedermayr, Helmut Ellemunter

Clin Case Rep· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Malignancies in patients with cystic fibrosis: a case series.
Dorothea Appelt, Teresa Fuchs, Gratiana Steinkamp, Helmut Ellemunter

J Med Case Rep· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ivacaftor Reduces Inflammatory Mediators in Upper Airway Lining Fluid From Cystic Fibrosis Patients With a G551D Mutation: Serial Non-Invasive Home-Based Collection of Upper Airway Lining Fluid.
Jochen G Mainz, Christin Arnold, Kara Wittstock, Uta-Christina Hipler, Thomas Lehmann, Helmut Ellemunter

Front Immunol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insights Into Patient Variability During Ivacaftor-Lumacaftor Therapy in Cystic Fibrosis.
Patrick O Hanafin, Isabelle Sermet-Gaudelus, Matthias Griese, Matthias Kappler, Helmut Ellemunter

Front Pharmacol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reference Values Matter: Fewer Patients With Malnutrition Using American Compared to More Recent German Growth Charts.
Helmut Ellemunter, Markus Dumke, Gratiana Steinkamp

J Pediatr Gastroenterol Nutr· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cystic Fibrosis Newborn Screening in Austria Using PAP and the Numeric Product of PAP and IRT Concentrations as Second-Tier Parameters.
Maximilian Zeyda, Andrea Schanzer, Pavel Basek, Vera Bauer, Ernst Eber, Helmut Ellemunter

Diagnostics (Basel)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tezacaftor/ivacaftor in people with cystic fibrosis heterozygous for minimal function CFTR mutations.
Anne Munck, Eitan Kerem, Helmut Ellemunter, Daniel Campbell, Linda T Wang

J Cyst Fibros· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Polymorphisms Affecting IDO1 or IDO2 Activity Differently Associate With Aspergillosis in Humans.
Valerio Napolioni, Marilena Pariano, Monica Borghi, Vasilis Oikonomou, Claudia Galosi, Helmut Ellemunter

Front Immunol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lung clearance index to detect the efficacy of Aztreonam lysine inhalation in patients with cystic fibrosis and near normal spirometry - A single-centre feasibility study.
Helmut Ellemunter, Gratiana Steinkamp

PLoS One· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highly mucus permeating and zeta potential changing self-emulsifying drug delivery systems: A potent gene delivery model for causal treatment of cystic fibrosis.
Janine Griesser, Gergely Hetényi, Christoph Federer, Christian Steinbring, Helmut Ellemunter

Int J Pharm· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis